$457 Million is the total value of ORACLE INVESTMENT MANAGEMENT INC's 19 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 28.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| QDEL | Sell | QUIDEL CORP | $124,055,000 | -21.1% | 1,903,558 | -19.5% | 27.16% | -28.6% |
| AXDX | Sell | ACCELERATE DIAGNOSTICS INC | $96,095,000 | +0.8% | 4,187,145 | -2.0% | 21.04% | -8.7% |
| AMRN | Buy | AMARIN CORP PLCspons adr new | $95,182,000 | +485.4% | 5,850,151 | +11.2% | 20.84% | +430.3% |
| PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $50,787,000 | +47.4% | 9,387,634 | -3.3% | 11.12% | +33.5% |
| TSRO | Sell | TESARO INC | $20,177,000 | -40.6% | 517,235 | -32.3% | 4.42% | -46.2% |
| BIOL | BIOLASE INC | $12,779,000 | +71.1% | 6,173,250 | 0.0% | 2.80% | +54.9% | |
| OPK | OPKO HEALTH INC | $12,754,000 | -26.4% | 3,686,194 | 0.0% | 2.79% | -33.3% | |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $12,170,000 | -26.4% | 897,494 | -35.6% | 2.66% | -33.4% |
| CFRX | Buy | CONTRAFECT CORP | $8,798,000 | +23.4% | 4,250,384 | +31.8% | 1.93% | +11.8% |
| VRML | VERMILLION INC | $6,976,000 | -9.0% | 9,825,289 | 0.0% | 1.53% | -17.6% | |
| SLNO | SOLENO THERAPEUTICS INC | $5,266,000 | -7.7% | 2,438,060 | 0.0% | 1.15% | -16.4% | |
| AGEN | AGENUS INC | $3,209,000 | -5.7% | 1,499,540 | 0.0% | 0.70% | -14.6% | |
| AXDX | Buy | ACCELERATE DIAGNOSTICS INCcall | $2,993,000 | +42.1% | 967,900 | +59.3% | 0.66% | +28.7% |
| BIIB | BIOGEN INC | $2,250,000 | +21.8% | 6,368 | 0.0% | 0.49% | +10.3% | |
| VRAY | New | VIEWRAY INC | $2,030,000 | – | 216,862 | +100.0% | 0.44% | – |
| ADRO | Sell | ADURO BIOTECH INC | $820,000 | -60.6% | 111,542 | -62.4% | 0.18% | -64.2% |
| EPZM | Sell | EPIZYME INC | $306,000 | -82.2% | 28,884 | -77.3% | 0.07% | -83.9% |
| QDEL | Buy | QUIDEL CORPcall | $58,000 | -91.2% | 175,000 | +65.6% | 0.01% | -91.9% |
| PACB | New | PACIFIC BIOSCIENCES CALIF INcall | $46,000 | – | 50,000 | +100.0% | 0.01% | – |
| TSRO | Exit | TESARO INCcall | $0 | – | -11,000 | -100.0% | -0.02% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INCcall | $0 | – | -100,000 | -100.0% | -0.07% | – |
| MZOR | Exit | MAZOR ROBOTICS LTDcall | $0 | – | -135,300 | -100.0% | -0.17% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -39,887 | -100.0% | -0.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| OPKO HEALTH INC | 42 | Q3 2023 | 10.6% |
| PACIFIC BIOSCIENCES CALIF IN | 42 | Q3 2023 | 22.6% |
| BIOGEN INC | 42 | Q3 2023 | 0.6% |
| QUIDEL CORP | 36 | Q1 2022 | 52.5% |
| AMARIN CORP PLC | 31 | Q3 2021 | 23.1% |
| VERMILLION INC | 28 | Q1 2020 | 3.8% |
| AGENUS INC | 25 | Q3 2023 | 9.8% |
| TESARO INC | 23 | Q4 2018 | 27.8% |
| ACCELERATE DIAGNOSTICS INC | 23 | Q2 2023 | 23.0% |
| MAZOR ROBOTICS LTD | 20 | Q1 2018 | 18.0% |
View ORACLE INVESTMENT MANAGEMENT INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View ORACLE INVESTMENT MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.